z-logo
Premium
A novel stage‐specific antigen is expressed only in early stages of spermatogonia in Japanese eel, Anguilla japonica testis
Author(s) -
Kobayashi Tohru,
KajiuraKobayashi Hiroko,
Nagahama Yoshitaka
Publication year - 1998
Publication title -
molecular reproduction and development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.745
H-Index - 105
eISSN - 1098-2795
pISSN - 1040-452X
DOI - 10.1002/(sici)1098-2795(199812)51:4<355::aid-mrd1>3.0.co;2-g
Subject(s) - biology , spermatogenesis , oryzias , sertoli cell , antigen , antibody , immunohistochemistry , testicle , human chorionic gonadotropin , japanese eel , endocrinology , medicine , andrology , japonica , immunology , genetics , hormone , gene , botany
We produced an antibody that recognized only early stages of spermatogonia in Japanese eel testis. This antibody (anti‐spermatogonia‐specific antigen‐1, anti‐SGSA‐1) recognized a band of about 38 kDa in Western blot analysis of extracts from eel testis. This antigen was observed by immunohistochemistry only in type‐A and early type‐B spermatogonia and could not be seen in the late type‐B spermatogonia, which appeared after the initiation of spermatogenesis by a single injection of human chorionic gonadotropin. Immunoreactive SGSA‐1 was absent in spermatocytes, spermatids, spermatozoa, Sertoli cells, and interstitial Leydig cells. Similarly, this antigen was also detected only in type‐A/primary spermatogonia in the testes of two species of teleosts, medaka ( Oryzias latipes ) and tilapia ( Oreochromis niloticus ), as well as a toad ( Xenopus laevis ). These results imply that the disappearance of SGSA‐1 in late type‐B/secondary spermatogonia is a critical step in the progression of spermatogenesis, and indicate that anti‐SGSA‐1 is a useful marker for analysis of the molecular mechanism controlling the differentiation of spermatogonia in lower vertebrates. Mol. Reprod. Dev. 51:355–361, 1998. © 1998 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here